Onyx Pharmaceuticals Announces Third Quarter 2008 Financial Results Teleconference And Webcast

Emeryville, CA — Oct. 29, 2008

Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will webcast a teleconference with management to discuss third quarter 2008 financial results and provide a general business overview on Thursday, November 06, 2008, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Financial results for the third quarter ended September 30, 2021 will be released earlier that day.

Interested parties may access a live webcast of the presentation on our website at:
http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

or by dialing 847-413-3235 and using the passcode 22936749. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3044 and using the passcode 22936749 approximately one hour after the teleconference concludes. The replay will be available through December 06, 2008.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treatedTM. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar®, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer, and other cancers. For more information about Onyx, visit the company’s website at www.onyx-pharm.com.

Nexavar® (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.

Return to 2008 Press Releases